Essential Partners’s iTeos Therapeutics ITOS Stock Holding History

Essential Partners’s Portfolio ITOS Stock Details ITOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-378	Closed	-$3.77K	–	2731
2025 Q2	$3.77K	Buy	+378	New	+$3.04K	﹤0.01%	1135

Other funds holding ITOS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Essential Partners's ITOS Position: Q3 2025 in Review

Essential Partners sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 378 shares — an estimated $3.77K sold.

Essential Partners first reported a position in ITOS in Q2 2025 and held it in 1 quarter. The position peaked at $3.77K in Q2 2025. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

Essential Partners reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
Essential Partners sold 378 iTeos Therapeutics shares in Q3 2025, an estimated $3.77K.
Essential Partners first reported a position in iTeos Therapeutics in Q2 2025 and held it in 1 quarter.
Essential Partners's iTeos Therapeutics position peaked at $3.77K in Q2 2025.
1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on Essential Partners's 13F filing for Q3 2025, filed 21 May 2026.